Rutgers Cancer Institute | Strategic Alliance Partners
Latest from Rutgers Cancer Institute


From radiopharmaceuticals to hypofractionated radiation therapy, one expert explained the current landscape of radiation treatments for prostate cancer.

One expert explains how bispecific antibodies are a ‘targeted and effective’ option for patients with multiple myeloma.